Les publications

Page en cours de mise à jour... Retrouvez ici les publications des équipes de recherche du CGO

408 publications
Année de publication :
Réseaux :

Complete Metabolic Response Assessed by FDG PET/CT to FOLFOXIRI-Bevacizumab in First-Line Treatment of BRAFV600E Mutated Metastatic…

Triplet chemotherapy (FOLFOXIRI) + bevacizumab regimen is indicated as first-line treatment of BRAF-mutated metastatic colorectal cancer (mCRC).

  • Ref: Clin Nucl Med. 2020 Sep;45(9):707-708.
  • Année de publication : 2020
  • Auteurs : Amrane K, le Pennec R, Schick U, Metges JP, Abgral R.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

Sonic Hedgehog Signature in Pediatric Primary Bone Tumors: Effects of the GLI Antagonist GANT61 on Ewing’s…

Osteosarcoma (OS) and Ewing’s sarcoma (ES) are the most common malignant bone tumors in children and adolescents. In many cases, the prognosis remains very poor. The Sonic hedgehog (SHH) signaling pathway, strongly involved in the development of many cancers, regulate transcription via the transcriptional factors Gli1-3.

  • Ref: Cancers (Basel). 2020 Nov 19;12(11):3438.
  • Année de publication : 2020
  • Auteurs : Mullard M, Cadé M, Morice S, Dupuy M, Danieau G, Amiaud J, Renault S, Lézot F, Brion R, Thepault RA, Ory B, Lamoureux F, Corre I, Brounais-LeRoyer B, Rédini F, Verrecchia F.
  • Réseaux : Réseaux: « Niches et Epigénétique des Tumeurs » & « Vectorisation, Imagerie, Radiothérapies »
Lire la publication

GETUG-AFU 17 : étude de phase III randomisée comparant la radiothérapie adjuvante à la radiothérapie de…

La radiothérapie adjuvante (aRT) réduit le risque de rechute biochimique chez les patients atteints d’un cancer de la prostate traités par une prostatectomie radicale (RP). L’étude GETUG-AFU 17 a comparé l’efficacité et la toxicité de l’aRT par rapport à la radiothérapie de rattrapage précoce (sRT), associée à un traitement hormonal.

  • Ref: Prog Urol. 2020 Nov;30(13):733-734.
  • Année de publication : 2020
  • Auteurs : Sargos P, Chabaud S, Latorzeff I, Magné N, Benyoucef A, Supiot S, Pasquier D, Abdiche S, Gilliot O, Graff-Cailleaud P, Silva M, Bergerot P, Baumann P, Belkacemi Y, Azria D, Brihou M, Soulié M, Richaud P.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies » & « Cancers des Tissus Hormono-dépendants »
Lire la publication

In Vivo Albumin-Binding of a C-Functionalized Cyclam Platform for 64 Cu-PET/CT Imaging in Breast Cancer Model.

An improved glucose-chelator-albumin bioconjugate (GluCAB) derivative, GluCAB-2Mal , has been synthesized and studied for in vivo 64 Cu-PET/CT imaging in breast cancer mice models together with its first-generation analogue GluCAB-1Mal . The radioligand works on the principle of tumor targeting through the enhanced permeability and retention (EPR) effect with a supportive role played by glucose metabolism. [64 Cu]Cu-GluCAB-2Mal (99 % RCP) exhibited high serum stability with immediate binding to serum proteins.

  • Ref: ChemMedChem. 2020 Nov 15.
  • Année de publication : 2020
  • Auteurs : Le Bihan T, Driver CHS, Ebenhan T, Le Bris N, Zeevaart JR, Tripier R.
  • Réseaux : Réseaux: « Vectorisation, Imagerie, Radiothérapies » & « Cancers des Tissus Hormono-dépendants »
Lire la publication

Comparison of survival outcomes between laparoscopic and abdominal radical hysterectomy for early-stage cervical cancer: A French…

Objectives: A recent randomized controlled trial has reconsidered the use of laparoscopy for treating patients with early-stage cervical cancer with radical hysterectomy (RH). We aimed to evaluate if surgical approach had an impact on surgical and oncological outcomes in these patients in a French setting.

  • Ref: J Gynecol Obstet Hum Reprod. 2020 Dec 16;50(2):102046.
  • Année de publication : 2020
  • Auteurs : Zaccarini F, Santy A, Dabi Y, Lavoue V, Carcopino X, Bendifallah S, Benbara A, Collinet P, Canlorbe G, Raimond E, Graesslin O, Ouldamer L, Daraï E, Huchon C, Golfier F, Touboul C, Bolze PA.
  • Réseaux : Réseaux: « Immunothérapies »
Lire la publication

Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis.

In most autoimmune disorders, crosstalk of B cells and CD4 T cells results in the accumulation of autoantibodies. In autoimmune hepatitis (AIH), the presence of anti-soluble liver antigen (SLA) autoantibodies is associated with reduced overall survival, but the associated autoreactive CD4 T cells have not yet been characterised.

  • Ref: J Hepatol. 2020 Dec;73(6):1379-1390.
  • Année de publication : 2020
  • Auteurs : Renand A, Cervera-Marzal I, Gil L, Dong C, Garcia A, Kervagoret E, Aublé H, Habes S, Chevalier C, Vavasseur F, Clémenceau B, Cardon A, Judor JP, Mosnier JF, Tanné F, Laplaud DA, Brouard S, Gournay J, Milpied P, Conchon S.
  • Réseaux : Réseaux: « Immunothérapies »
Lire la publication

Anti-PD1 therapy induces lymphocyte-derived exosomal miRNA-4315 release inhibiting Bim-mediated apoptosis of tumor cells.

Anti-PD1 immunotherapy, as a single agent or in combination with standard chemotherapies, has significantly improved the outcome of many patients with cancers. However, resistance to anti-PD1 antibodies often decreases the long-term therapeutic benefits.

  • Ref: Cell Death Dis. 2020 Dec 11;11(12):1048.
  • Année de publication : 2020
  • Auteurs : Guyon, N., Garnier, D., Briand, J., Nadaradjane, A., Bougras-Cartron, G., Raimbourg, J., Campone, M., Heymann, D., Vallette, F. M., Frenel, J. S., & Cartron, P. F.
  • Réseaux : Réseaux: « Niches et Epigénétique des Tumeurs »
Lire la publication

DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple…

Multiple myeloma (MM) is a heterogeneous plasma cell malignancy that remains challenging to cure. Global hypomethylation correlates with an aggressive phenotype of the disease, while hypermethylation is observed at particular regions of myeloma such as B cell-specific enhancers.

  • Ref: Clin Epigenetics. 2020 Nov 2;12(1):163.
  • Année de publication : 2020
  • Auteurs : Alberge JB, Magrangeas F, Wagner M, Denié S, Guérin-Charbonnel C, Campion L, Attal M, Avet-Loiseau H, Carell T, Moreau P, Minvielle S, Sérandour AA.
  • Réseaux : Réseaux: « Niches et Epigénétique des Tumeurs »
Lire la publication

Narrow resection margins are not associated with mortality or recurrence in patients with Merkel cell carcinoma:…

Background: Wide local excision constitutes the standard of care for Merkel cell carcinoma, but the optimal margin width remains controversial.

Objectives: To assess whether narrow margins (0.5-1 cm) were associated with outcome.

  • Ref: J Am Acad Dermatol. 2020 Nov 27:S0190-9622(20)33079-6.
  • Année de publication : 2020
  • Auteurs : Jaouen F, Kervarrec T, Caille A, Le Corre Y, Dreno B, Esteve E, Wierzbicka-Hainaut E, Maillard H, Dinulescu M, Blom A, Saïag P, Samimi M.
  • Réseaux : Réseaux: « Immunothérapies »
Lire la publication

Involvement of GPx-3 in the Reciprocal Control of Redox Metabolism in the Leukemic Niche.

The bone marrow (BM) microenvironment plays a crucial role in the development and progression of leukemia (AML). Intracellular reactive oxygen species (ROS) are involved in the regulation of the biology of leukemia-initiating cells, where the antioxidant enzyme GPx-3 could be involved as a determinant of cellular self-renewal.

  • Ref: Int J Mol Sci. 2020 Nov 14;21(22):8584.
  • Année de publication : 2020
  • Auteurs : Vignon C, Debeissat C, Bourgeais J, Gallay N, Kouzi F, Anginot A, Picou F, Guardiola P, Ducrocq E, Foucault A, Ravalet N, Le Nail LR, Domenech J, Béné MC, Le Bousse-Kerdilès MC, Gyan E, Herault O.
  • Réseaux : Réseaux: « Niches et Epigénétique des Tumeurs »
Lire la publication